A report from bioLIVE has forecasted that outsourcing will play an increasing role in the bio supply chain and that continuous manufacturing, API and process analytical technology (PAT) expertise will be vital to future growth.
In this online exclusive, Brady Haggstrom, IDBS, looks at the changing landscape of drug development and delivery, which is more and more outsourced nowadays, and how technology can help protect sensitive research data.
CDMO, Recipharm, has acquired Sanofi’s manufacturing centre and business located in Holmes Chapel, which will provide the company with a platform to take advantage of the growing respiratory drug market.
As more pharma manufacturers outsource elements of their process, Steve Cottrell, president at Maetrics, looks at the importance of supply chain visibility and how companies can regain full control.
Here, Dale Pittock, sales director of pharmacy packaging provider Valley Northern, explains how contract packaging can support pharmaceutical innovation.
Full-service contract manufacturer of biopharmaceutical proteins, Wacker Biotech, has obtained US Food and Drug Administration (FDA) approval to manufacture reteplase — the active ingredient in the drug Retavase.
Mark Quick, executive vice president of corporate development, Recipharm, goes into detail about the opportunities his company has faced this year as well as the challenges.
Manuel Leal, business development director, Idifarma, reveals what he believes have been the best opportunities, the biggest changes and most influential trends of the year.
STA Pharmaceutical has reported rapid growth in companies intending to market their products in China using it as a partner following the CFDA announcement of the Market Authorization Holder (MAH) pilot programme last year
